You just read:

Ultragenyx Pharmaceutical and Arcturus Therapeutics Announce a Research Collaboration and License Agreement to Develop RNA Therapeutics for Rare Diseases

News provided by

Arcturus Therapeutics, Inc.

Oct 29, 2015, 05:01 ET